In an interview published on 26 February 2026, Vitalant describes the evolution of its Cayman captive and the possibility of changing retentions, limits and financing arrangements. The portfolio has expanded to include medical stop-loss and employment-related exposures, providing a concrete connection between captive strategy and employee benefits. The interview makes an important distinction about reinsurance: it is being considered, but is not yet in place in the account reviewed.